Pneumococcal synergism
(Unterschied zwischen Versionen)
| Zeile 11: | Zeile 11: | ||
until further humanized work by me, | until further humanized work by me, | ||
| − | {{plb|((covid19+OR+covid-19+OR+sars-cov2+OR+sars-cov-2+OR+2019-ncov+OR+2019ncov))+AND+(pneumococc*+OR+streptococc*+OR+ | + | {{plb|((covid19+OR+covid-19+OR+sars-cov2+OR+sars-cov-2+OR+2019-ncov+OR+2019ncov))+AND+(pneumococc*+OR+streptococc*+OR+s.pneumoniae)|covid19 & pneumococci}} |
Version vom 25. April 2021, 17:27 Uhr
| Immunology |
Pneumococcal colonization means synergism with sars cov2 ad disease expression. 13-valent pneumococcal vaccination reduces death/severity/incidence by some 30 percent, upto 90 days preexposure to antibiotics similar. 13-valent vaccination reduces surface colonization bey pneumococci, 23 valent does not.
index paper is
| 33693636 2021. Prevention of COVID-19 among older adults receiving pneumococcal conjugate vaccine suggests interactions between Streptococcus pneumoniae and SARS-CoV-2 in the respiratory tract |
until further humanized work by me,
| living current stringent pubmed readout on covid19 & pneumococci |
